Related Experiment Videos
Insights
Ophthalmoplegic migraine (OM) is rare in young children. A 12-month-old girl with OM showed improvement after propranolol treatment, suggesting a potential therapeutic option.
Area of Science:
- Pediatric Neurology
- Ophthalmology
- Neuroscience
Background:
- Isolated oculomotor nerve palsy is uncommon in pediatric patients.
- Ophthalmoplegic migraine (OM), characterized by third nerve weakness, is a rare complication of vascular headaches, particularly in young children.
Observation:
- A case study involved a 12-month-old female infant presenting with ophthalmoplegic migraine.
- The infant exhibited symptoms consistent with third nerve palsy.
Findings:
- The pediatric patient with ophthalmoplegic migraine demonstrated a positive response to propranolol therapy.
- This suggests propranolol may be an effective treatment for OM in very young children.
Implications:
- This case highlights the possibility of OM in infants and the potential efficacy of beta-blockers.
- Further research is warranted to explore propranolol's role in managing pediatric ophthalmoplegic migraine.
- Early diagnosis and intervention may improve outcomes for children with OM.
Abstract:
Isolated oculomotor nerve palsy is an unusual finding in the pediatric patient. Third nerve weakness is a rare complication of vascular headaches, and there are few reported cases of so-called ophthalmoplegic migraine (OM) in young children. Recently we have seen a 12-month-old girl with OM that appeared to respond to treatment with propranolol.